Arthritis Research UK is the resource for anyone looking for the latest news in the fight against arthritis. We’re providing answers today and tomorrow toward a future free from arthritis.
A maximum of 200 results have been returned
A new kinase protein inhibitor therapy has been developed by US researchers that can potentially prevent cartilage and bone destruction in rheumatoid arthritis.
Find out more
US researchers have identified a new drug target for the treatment of rheumatoid arthritis that focuses on the cells directly responsible for cartilage damage in affected joints.
People with depression have an increased risk of developing episodes of lower back pain, according to research.
A real-world US study has shown that febuxostat is more effective than allopurinol in reducing serum urate levels in gout patients.
A new study has indicated that subcutaneous methotrexate can offer benefits compared to oral options for the treatment of early rheumatoid arthritis.
A new combination of 3D printed microfibre scaffolding and hydrogels has been shown to be an effective method of creating artificial cartilage.
Bisphosphonates can decrease the risk of vertebral and nonvertebral fractures and increase bone mineral density in men with osteoporosis, according to a study.
More intensive DMARD treatment strategies can increase the chances of achieving drug-free sustained remission, according to a new study.
A Swedish population study has shed new light on the prevalence of ankylosing spondylitis, including the role played by gender differences, environmental factors and socioeconomic background.
A new UK study has offered evidence of seasonal changes in immune system activity that could explain why conditions such as rheumatoid arthritis tend to be aggravated in winter.